Sign in
ELYM Stock Price, Chart, Stats & News
Eliem Therapeutics, Inc.
Save
Eliem Therapeutics, Inc. (ELYM) does not currently pay a dividend.
342.68M
Market cap
–
Current P/E
–
Forward P/E
ELYM chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -35.68% |
ROE | -33.41% |
D/E | 0.00x |
Interest coverage ratio | – |
ELYM valuation
P/E | – |
P/S | – |
P/B | 2.16x |
P/CF | -6.38x |
P/FCF | -6.28x |
P/OCF | -6.38x |
PEG | 0.01x |
EV multiple | -5.57x |
About
Eliem Therapeutics, Inc. is a clinical-stage biotechnology firm focused on developing therapeutic solutions for conditions characterized by abnormal neuronal excitability. The company aims to fulfill significant unmet medical needs in areas such as chronic pain management, neuropsychiatric illnesses, epilepsy, and other disorders affecting the central and peripheral nervous systems. Their developmental pipeline is highlighted by two primary drug candidates.
Similar securities
Based on sector and market capitalization
Report issue